Showing results (11-20 of 721) with videos related to
Sort By:
Pageof 73
Neuropsychobiology|January 1, 1975
Rebound phenomena in manic patients following physostigmine. Preliminary observationsB Shopsin, D Janowsky, J Davis, et al.Archives of General Psychiatry|January 1, 1975
Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidolB Shopsin, S Gershon, H Thompson, et al.Psychopharmacology Communications|January 1, 1975
Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patientsB Shopsin, S Gershon, M Goldstein, et al.Neuropsychobiology|January 1, 1976
Genetics of affective disorders. II. Morbidity risk and genetic transmissionB Shopsin, J Mendlewicz, L Suslak, et al.Neuropsychobiology|January 1, 1976
Genetics of affective disorders. I. Familial incidence study of bipolar, unipolar and schizo-affective illnessesL Suslak, B Shopsin, E Silbey, et al.Psychopharmacology|December 19, 1977
Dopaminergic agonist properties of ephedrine--theoretical implicationsB Angrist, J Rotrosen, D Kleinberg, et al.The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1980
Sodium valproate in schizophrenia: some biochemical correlatesA Lautin, B Angrist, M Stanley, et al.Journal of Neural Transmission|January 1, 1979
Behavioral and neuroendocrine effects of low dose ET-495: antagonism by haloperidolB Angrist, M Ain, J Rotrosen, et al.The American Journal of Psychiatry|August 1, 1978
Suppression of prolactin by dopamine agonists in schizophrenics and controlsJ Rotrosen, B Angrist, C Clark, et al.Pageof 73